# Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes

Source: https://welltoldgrants.com/grants/rfa-dp-22-001-real-world-effectiveness-of-structured-lifestyle/  
Official notice: https://www.grants.gov/search-results-detail/334359

> Centers for Disease Control and Prevention - ERA offered grants of up to $570,000 to any type of organization. It expected to make about 6 awards worth $16.0 million in total. Applications closed on February 1, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-DP-22-001 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | February 1, 2022 |
| Award ceiling | $570,000 |
| Award floor | not stated |
| Expected awards | 6 |
| Total funding | $16.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.068 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

For an applicant to be even considered they must be responsive to the following. Component A - Longitudinal Cohort: Applicants must provide evidence of being able to access electronic records for building a cohort of individuals meeting eligibility criteria for the NDPP/MDPP (both participated in the NDPP/MDPP and not participated but eligible for the NDPP/MDPP program), individual program participation information of the NDPP/MDPP participants, medical records and health services utilization and cost data of all study participants. A minimum number of 5,000 NDPP/MDPP program enrollees and equal or a greater number of matched controls is required per applicant. If the application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. Component B - Coordinating Center: Not Applicable

## What the grant funds

The purpose of this Notice of Funding Opportunity Announcement (NOFO) is to assess the long-term effectiveness, cost-effectiveness, and barriers to enrollment in or completion of structured lifestyle interventions (SLI), as implemented by the National Diabetes Prevention Program (NDPP). This NOFO has two (2) components to achieve the purpose of the program: Component A: To evaluate the long-term (≥5 years) effectiveness and cost-effectiveness of SLI participants, and identify barriers to participation and adherence in these SLI programs, overall and by age group, sex, race/ethnicity, and socio-economic status. The study participants are those who meet the NDPP eligibility criteria and completed the NDPP curriculum. The study will also include a control group consisting of individuals who meet the NDPP eligibility criteria but are either not enrolled in the SLI program or do not complete it. Applicants shall connect individual level data from SLI program providers, electronic health records and claims with follow up information on the study participants for a minimum of 5 years. The study shall include SLI delivered in person, virtually, and a combination of the two. Component B: The Coordinating Center provides the infrastructure for data storage (if needed), harmonizing data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.

## Questions people ask

### Is RFA-DP-22-001 still open?

No. It closed on February 1, 2022. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.

### Who can apply for Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes?

Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes?

Closed February 1, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $570,000 each. About $16.0 million in total across about 6 awards.

### Who has won Chronic Diseases:  Research, Control, and Prevention   grants before?

The largest recipients over five fiscal years were New York University, American College of Rheumatology, Inc, Lupus Foundation of America Inc. The program made 88 awards worth $57.3 million in that time.